Home | Articles
Published on:September 2017
Indian Journal of Pharmaceutical Education and Research, 2017; 51(3s2):s417-s420
Research Article | doi:10.5530/ijper.51.3s.59

Angiotensin-Converting Enzyme (ACE) Inhibitory Effects of Hazelnut Protein Hydrolysate Prepared Using Pepsin


Authors and affiliation (s):

Evren Caglar Eroglu1*, Salih Aksay2

1Alata Horticultural Research Institute, Department of Postharvest Physiology, Mersin, TURKEY.
2University of Mersin, Department of Food Engineering, Mersin, TURKEY.

Abstract:

Objective / Purpose: The aim of this study is to find out the effect of protein isolate and pepsin hydrolysates of hazelnut protein on Angiotensin-Converting Enzyme (ACE) inhibition. Material and Methods: Unshelled hazelnuts (Corylus avellana L.) was firstly grinded and defatted by petroleum ether. Alkaline extraction and isoelectric precipitation method was used in order to obtain protein isolate. Neutralized protein suspension was freeze dried before analysis and stored at -18ºC. Pepsin hydrolysis was conducted at pH 2 with 1:20 (w:w) enzyme/substrate ratio at 37ºC for 60 min. Hydrolysis was stopped by heating samples to 85ºC for enzyme inactivation and hydrolysates were analyzed for ACE inhibitory effect. 100 μL of 2 mM HHL, 20 μL of hydrolysate and 20 μL of 2 mU of ACE were incubated in 37ºC for 60 min. Reaction was terminated by adding 85 μl of 1 M HCl. Shimadzu HPLC system with C18 column and DAD was used for ACE inhibition analysis. Results and Discussion: Hazelnut protein isolate and peptides have over 95% ACE inhibition. On the other hand, IC50 values of samples taken at 0, 30 and 60 minutes of pepsin hydrolysis were 1.29 mg protein/ml, 0.25 mg protein/mL and 0.22 mg protein/mL, respectively. Conclusion: Results shows that hazelnut protein isolate and peptides have reasonable ACE inhibition properties. Pepsin hydrolysates of hazelnut isolates gives almost 6 times more anti-hypertensive activity than hazelnut protein isolate.

Key words: Hazelnut, Pepsin Hydrolysis, ACE Inhibition, Anti-Hypertensive.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs